Prediction of New-Onset Diabetes Mellitus within 12 Months after Liver Transplantation—A Machine Learning Approach
暂无分享,去创建一个
T. Luedde | S. Loosen | C. Roderburg | K. Kostev | A. Krieg | Sarah Krieg | Saket Chaudhari | Swati Upadhyaya
[1] Zhen Zhang,et al. Progress of new-onset diabetes after liver and kidney transplantation , 2023, Frontiers in Endocrinology.
[2] J. Tanner,et al. Effects of Intensive Blood Glucose Control on Surgical Site Infection for Liver Transplant Recipients: A Randomized Controlled Trial. , 2022, Transplantation proceedings.
[3] N. Syn,et al. A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] L. Rostaing,et al. Adverse effects of immunosuppression after liver transplantation. , 2021, Best practice & research. Clinical gastroenterology.
[5] M. Woo,et al. Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] L. Nguyen,et al. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies , 2020, Gut.
[7] Anna Goldenberg,et al. Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review , 2020, Hepatology.
[8] E. Gorokhova,et al. Disparate effects of antibiotic-induced microbiome change and enhanced fitness in Daphnia magna , 2019, bioRxiv.
[9] K. Watt,et al. New‐Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long‐Term Survival After Liver Transplant: A Machine Learning Approach , 2018, Mayo Clinic proceedings.
[10] W. Rathmann,et al. Basic characteristics and representativeness of the German Disease Analyzer database . , 2018, International journal of clinical pharmacology and therapeutics.
[11] Peer Bork,et al. Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.
[12] Lanjuan Li,et al. The Origin of New-Onset Diabetes After Liver Transplantation: Liver, Islets, or Gut? , 2016, Transplantation.
[13] Tianqi Chen,et al. XGBoost: A Scalable Tree Boosting System , 2016, KDD.
[14] Tim D Spector,et al. Proton pump inhibitors alter the composition of the gut microbiota , 2015, Gut.
[15] Jingyuan Fu,et al. Proton pump inhibitors affect the gut microbiome , 2015, Gut.
[16] T. M. A. Fernandez,et al. Critical Care of the Liver Transplant Recipient , 2015, Current Anesthesiology Reports.
[17] M. Senzolo,et al. Perioperative thrombotic complications in liver transplantation. , 2015, World journal of gastroenterology.
[18] B. Müllhaupt,et al. Challenges to liver transplantation and strategies to improve outcomes. , 2015, Gastroenterology.
[19] G. Dedemadi,et al. Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review. , 2014, World journal of gastroenterology.
[20] S. Mallett,et al. Transfusion and coagulation management in liver transplantation. , 2014, World journal of gastroenterology.
[21] Q. Xia,et al. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: A systematic review and meta‐analysis , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] H. Ohdan,et al. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. , 2014, Transplantation proceedings.
[23] O. Dirsch,et al. Liver transplantation and inflammation: is lipopolysaccharide binding protein the link? , 2013, Cytokine.
[24] D. Slakey,et al. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation. , 2013, Transplantation reviews.
[25] Zhuye Jie,et al. Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance , 2013, PloS one.
[26] E. Porrini,et al. The Higher Diabetogenic Risk of Tacrolimus Depends on Pre‐Existing Insulin Resistance. A Study in Obese and Lean Zucker Rats , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] K. Clément,et al. Gut microbiota and non-alcoholic fatty liver disease: new insights. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[28] L. Mandarino,et al. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. , 2013, Transplantation.
[29] B. Stecher,et al. 'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution , 2013, Nature Reviews Microbiology.
[30] Haiyang Xie,et al. Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population. , 2013, Journal of hepatology.
[31] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[32] A. Burroughs,et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). , 2012, Journal of hepatology.
[33] Shu-sen Zheng,et al. Changes of gut bacteria and immune parameters in liver transplant recipients. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.
[34] Ian R. Lanza,et al. Unique Cellular and Mitochondrial Defects Mediate FK506-Induced Islet &bgr;-Cell Dysfunction , 2011, Transplantation.
[35] J. Sonnenburg,et al. Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota Alterations , 2010, Cell.
[36] B. Müllhaupt,et al. Current and future trends in liver transplantation in Europe. , 2010, Gastroenterology.
[37] D. Samuel,et al. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[38] William M. Lee,et al. Acute liver failure: Summary of a workshop , 2007, Hepatology.
[39] M. Márques,et al. Tacrolimus‐Induced Diabetes in Rats Courses with Suppressed Insulin Gene Expression in Pancreatic Islets , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] K. Wernecke,et al. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living‐donor liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[41] J. Figueras,et al. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study. , 2006, Journal of hepatology.
[42] R. Fisher,et al. Four‐year follow‐up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation , 2004, Clinical transplantation.
[43] F. Cosio,et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. , 2002, Kidney international.
[44] Lucila Ohno-Machado,et al. Logistic regression and artificial neural network classification models: a methodology review , 2002, J. Biomed. Informatics.
[45] Michael Keith. Random Forest , 2021, Machine Learning with Regression in Python.
[46] A. Burroughs,et al. EASL Clinical Practice Guidelines: Liver transplantation. , 2016, Journal of hepatology.